Advancing Precision Care and Shared Decision-making in 1L HER2-Positive mBC Management: Expert Insights, Patient Resources, and Adaptive Decision Support

Learn about the latest clinical trial evidence for treating patients with HER2-positive metastatic breast cancer using antibody–drug conjugates in the earlier-line setting and learn how to engage in smart patient-oriented conversations regarding the use of novel treatments, managing adverse effects, and treatment adherence with downloadable resources; an on-demand webcast with accompanying slides; podcasts; an expert-authored clinical commentary; patient case vignettes; and an interactive decision support tool to support your practice.

Share

Program Content

Events

  • Live Event Advancing Precision Care and Shared Decision-making in 1L HER2+ mBC Management: Expert Insights, Patient Resources, and Adaptive Decision Support
    Advancing Precision Care and Shared Decision-making in 1L HER2+ mBC Management: Expert Insights, Patient Resources, and Adaptive Decision Support
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

1L HER2-Positive mBC
Oncologist On-Call: Thoughts on the Current Treatment Landscape for First-line Management of HER2-Positive mBC
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: March 25, 2025

Expires: March 24, 2026

Activities

mBC Patient Resource
Newly Diagnosed With HER2-Positive Metastatic Breast Cancer? Take the Lead in Your Treatment Journey
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 24, 2025

Expires: March 23, 2026

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC. in collaboration with Smart Patients.

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Smart Patients

ProCE Banner